OR6A2 on immune cells and heart recovery after heart attack
Part of Heart & circulation clinical trials.
This study looks at a molecule called OR6A2 on certain immune cells (monocytes) in people who have had a heart attack treated with a stent. It aims to see if this molecule is linked to heart recovery and future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You've had a heart attack confirmed by a special X-ray (angiogram) and received a stent procedure (PCI).
- After the procedure, doctors noted damage to your heart muscle caused by restoring blood flow (ischemia-reperfusion injury).
- You are between 18 and 90 years old.
- You do not have an active infection.
- You have not had advanced heart failure (class III or IV), a recent stroke or brain event, active heart muscle inflammation (myocarditis), or serious heart rhythm problems.
- You have not been treated for cancer (except non-melanoma skin cancer) in the last 5 years, and your liver and kidney function are adequate (no severe kidney failure or advanced liver disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at RNA markers in the blood of people having their first heart attack to see if they can predict recovery. If you are scheduled for a procedure to open blocked arteries, you may be able to join.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
This study is looking at certain blood markers and heart tissue changes in people who have recently had a heart attack. The goal is to understand how the heart heals and remodels after an attack, which could help improve future treatments.
This study looks at blood tests and heart function after a first heart attack (STEMI) treated with emergency stenting. Researchers want to see if certain molecules in the blood can predict future heart problems.
This study looks at how immune cells change in the first few hours after a severe heart attack (STEMI) and how that relates to early scar healing. It may help doctors understand why some patients heal better than others.
This study looks at whether certain blood markers (related to inflammation and heart damage) can help tell how well your heart is working after a heart attack. By joining, you could help doctors better predict heart function problems and improve care for future patients.
Hear when a new Myocardial Ischemia-Reperfusion Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.